Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.30USD
6:08pm GMT
Change (% chg)

$0.14 (+3.37%)
Prev Close
$4.16
Open
$5.00
Day's High
$5.35
Day's Low
$4.21
Volume
244,968
Avg. Vol
13,143
52-wk High
$5.85
52-wk Low
$2.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.454
Mar '18 0.00 -1.027
FY 2017 Dec '17 0.00 -0.625
Sep '17 0.00 -0.296
Jun '17 0.00 -0.288
Mar '17 0.00 -0.079
FY 2016 Dec '16 0.00 -0.098
Sep '16 0.00 -0.065
Jun '16 0.00 -0.092
Mar '16 0.00 -0.126
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 2 -0.38 -0.35 -0.42 --
Quarter Ending Mar-19 1 -0.56 -0.56 -0.56 --
Year Ending Dec-18 2 -2.08 -2.01 -2.15 --
Year Ending Dec-19 2 -1.39 -1.22 -1.57 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.00 29.57
P/E High - Last 5 Yrs. -- 41.53 46.44
P/E Low - Last 5 Yrs. -- 23.57 24.51
Beta -- 0.90 0.88
Price to Sales (TTM) -- 12.73 15.43
Price to Book (MRQ) 8.75 3.77 4.06
Price to Tangible Book (MRQ) 8.75 14.59 13.80
Price to Cash Flow (TTM) -- 20.10 21.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.75 1.64
Dividend Yield - 5 Year Avg -- 1.52 1.45
Dividend 5 Year Growth Rate -- -8.60 -5.78
Payout Ratio(TTM) -- 44.96 41.88

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.92 7.10
Sales (TTM) vs TTM 1 Yr. Ago -- 4.10 5.63
Sales - 5 Yr. Growth Rate -- 6.79 7.39
EPS (MRQ) vs Qtr. 1 Yr. Ago -57.49 41.95 36.31
EPS (TTM) vs TTM 1 Yr. Ago -352.69 -- --
EPS - 5 Yr. Growth Rate -- 6.65 7.73
Capital Spending - 5 Yr. Growth Rate -- 7.62 8.00

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.56 2.55
Current Ratio (MRQ) 2.14 3.53 3.51
LT Debt to Equity (MRQ) 0.00 8.99 11.13
Total Debt to Equity (MRQ) 0.00 12.35 14.84
Interest Coverage (TTM) -2.46 47.44 40.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.38
Gross Margin - 5 Yr. Avg. -- 53.04 52.96
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.47 15.85
Operating Margin (TTM) -- 12.15 -16.28
Operating Margin - 5 Yr. Avg. -- 14.17 11.08
Pre-Tax Margin (TTM) -- 12.84 -14.67
Pre-Tax Margin - 5 Yr. Avg. -- 14.60 11.39
Net Profit Margin (TTM) -- 9.34 -18.01
Net Profit Margin - 5 Yr. Avg. -- 10.83 7.65
Effective Tax Rate (TTM) -- 21.45 21.32
Effective Tax Rate - 5 Yr. Avg. -- 23.88 24.45

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 833,043,813 722,980,797
Net Income/Employee (TTM) -- 96,547,317 83,628,555
Receivable Turnover (TTM) -- 5.10 5.19
Inventory Turnover (TTM) -- 2.60 4.12
Asset Turnover (TTM) 0.00 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -109.76 10.61 10.15
Return on Assets - 5 Yr. Avg. -- 11.35 10.82
Return on Investment (TTM) -148.77 13.26 12.77
Return on Investment - 5 Yr. Avg. -- 14.61 13.88
Return on Equity (TTM) -150.59 15.04 14.47
Return on Equity - 5 Yr. Avg. -- 15.77 15.19
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -385.07 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avenue Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.14%
# of Holders: 10
Total Shares Held: 226,012
3 Mo. Net Change: 2,522
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 1
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.